Within pharmaceutical process development, chemicals previously synthesised at the milligram level require scaling up to gram levels and above. These are often novel chemicals or utilise large numbers ...

In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...

Providing support for downstream drug development has not traditionally been a primary focus of public research funding programmes. However, the European Commission has decided to include the drug ...

One of the greatest achievements in the history of biopharmaceuticals occurred in January 2020, when Pfizer and Moderna used genetic sequencing provided by Chinese laboratories to design mRNA vaccines ...

LOGAN, Utah--(BUSINESS WIRE)--Frontier Scientific, a world leader in porphyrin chemistry and chemical building blocks for drug discovery and material science research, today announced their ...

QbD is an industry initiative supported by regulators. However, it is also a systematic method of process development which delivers consistency, robustness and increased process knowledge. This ...

SOUTH CHARLESTON, W.Va.--(BUSINESS WIRE)--The Mid-Atlantic Technology, Research & Innovation Center (MATRIC ®) today announced it will establish the Center of Excellence (CoE) for process design, ...

Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...

SRI International announced today it is spinning off Synfini, a biosciences platform that accelerates the process by which pharmaceutical and other companies can design, synthesize, and bring to ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...